statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024...

Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Harrow Health (HROW Research Report) today and set a price target of $26.00...

Harrow Health's Growth Trajectory: A Buy Rating Amid Strong Product Performance and Strategic Market Investments

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Harrow Health says CMS notification 'very important development for IHEEZO'

Harrow Health backs 2024 revenue guidance of at least $180M, consensus $184.91M

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, announced results for the fourth quarter and year ended December 31, 2023. The Company also posted its fourth quarter and...

Harrow Announces Fourth Quarter and Year-End 2023 Financial Results

Harrow Health, Inc. (NASDAQ:HROW  Get Free Report) was the target of a significant increase in short interest in February. As of February 29th, there was short interest totalling 5,490,000...

Harrow Health, Inc. (NASDAQ:HROW) Short Interest Update

Kennedy Capital Management LLC purchased a new stake in Harrow Health, Inc. (NASDAQ:HROW  Free Report) during the third quarter, HoldingsChannel reports. The institutional investor purchased...

Kennedy Capital Management LLC Takes $1.75 Million Position in Harrow Health, Inc. (NASDAQ:HROW)

Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2023, on...

Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024

Harrow, Inc. (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, and Apotex Inc. (Apotex), Canadas largest pharmaceutical company, today jointly announced an exclusive out-licensing...

Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products

Allspring Global Investments Holdings LLC purchased a new position in Harrow Health, Inc. (NASDAQ:HROW  Free Report) during the 3rd quarter, according to the company in its most recent filing...

1,814 Shares in Harrow Health, Inc. (NASDAQ:HROW) Bought by Allspring Global Investments Holdings LLC

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.

Volume	280,144.00
52-Wk High	$28.25
52-Wk Low	$7.60

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.20	--	--	N/A
Q4'23	-$0.04	-$0.26	-500.00%	MISSED
Q3'23	$0.04	-$0.13	-454.54%	MISSED
Q2'23	-$0.04	-$0.14	-250.00%	MISSED
Q1'23	-$0.05	-$0.22	-312.50%	MISSED

HROW Harrow Health Inc

About

Feed

News

Earnings

Fundamentals